No new significant updates or guidelines matching this topic were found today. We will check again soon.
Lémann Index (Crohn's Digestive Damage)
Cumulative Digestive Damage • LI Staging
Segmental Evaluation
The Lémann Index requires detailed cross-sectional imaging (MRE/CTE) and pan-endoscopy to quantify structural lesions (strictures, fistulae, perianal ulcers). Utilize specialized LI software or scoring sheets for the full multi-segmental composite score.
Guidelines & Evidence
Verified
Last Review: 2026
When to Use
When to Use
Objective quantification of cumulative bowel damage in Crohn's disease (CD)
Measuring disease progression independent of current clinical symptoms (HBI/CDAI)
Evaluating the efficacy of "Treat-to-target" strategies in preventing long-term structural morbidity
Used primarily in clinical research and specialized IBD academic centers
Damage vs. Activity
The Lémann index measures irreversible structural changes (strictures, fistulas, resections), whereas the CDAI or HBI measures reversible inflammatory "activity." A patient can be in clinical remission but have a high Lémann Index.